EGFR and neoplasm: Indeed, the reported frequency of baseline EGFR p.T790M mutations varies widely in the literature, ranging from 1% of all EGFR-mutant lung cancers[11] to 35% of all EGFR-mutant lung cancers[20] and depends of the sensitivity of the assays used and their ability to identify minor clones within a tumor.